Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CGP049090 |
Synonyms | |
Therapy Description |
CGP049090 inhibits the interaction of CTNNB1 with TCF7L2 to block Wnt signaling and promote apoptosis (PMID: 20360943, PMID: 27602115). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CGP049090 | CTNNB1 Inhibitor 27 | CGP049090 inhibits the interaction of CTNNB1 with TCF7L2 to block Wnt signaling and promote apoptosis (PMID: 20360943, PMID: 27602115). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC inact mut | colon cancer | sensitive | CGP049090 | Preclinical | Actionable | In a preclinical study, CGP049090 inhibited proliferation of a colorectal cancer cell line harboring an APC inactivating mutation in culture (PMID: 14749129). | 14749129 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|